Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.


INTRODUCTION Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the treatment of choice for many patients suffering from hematological malignancies, severe hemoglobinopathies, bone marrow failures or severe primary immunodeficiencies. Graft rejection/failure (GF) is a life-threatening complication following allo-HSCT that is most commonly… (More)
DOI: 10.1517/14728214.2013.798642


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics